Paper1120218
I alpha-hydroxycholecalciferol: a treatment of renal bone disease.
Catto GR and 3 others. Br Med J, 1975. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. I alpha-hydroxycholecalciferol: a treatment of renal bone disease. Papers, record 1120218. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1120218
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Diseases | Major topic |
| Hydroxycholecalciferols | Major topic |
| Kidney Failure, Chronic | Major topic |
| Administration, Oral | |
| Adult | |
| Calcium | |
| Calcium Metabolism Disorders | |
| Humans | |
| Injections, Intravenous | |
| Intestinal Absorption | |
| Male | |
| Middle Aged |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14215559 | NEUTRON-ACTIVATION ANALYSIS IN MAN IN VIVO. A NEW TECHNIQUE IN MEDICAL INVESTIGATION. | Lancet | 1964 | https://conductscience.org/library/papers/14215559 | PubMed |
| 2 | 14072150 | BONE DISEASE IN CHRONIC RENAL FAILURE. | Q J Med | 1963 | https://conductscience.org/library/papers/14072150 | PubMed |
| 3 | 14000881 | A modified bone-biopsy drill for outpatient use. | Lancet | 1963 | https://conductscience.org/library/papers/14000881 | PubMed |
| 4 | 13721924 | The treatment of renal-glomerular osteodystrophy. | Q J Med | 1961 | https://conductscience.org/library/papers/13721924 | PubMed |
| 6 | 4578017 | The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4578017 | PubMed |
| 7 | 4704925 | Comparison of the stannous chloride and vanadate methods for estimation of serum inorganic phosphorus by use of the "SMA 12-60". | Clin Chem | 1973 | https://conductscience.org/library/papers/4704925 | PubMed |
| 8 | 4741371 | Partial body neutron activation analysis in vivo: a new approach to the investigation of metabolic bone disease. | Phys Med Biol | 1973 | https://conductscience.org/library/papers/4741371 | PubMed |
| 9 | 4111887 | Silver staining of bone prior to decalcification for quantitative determination of osteoid in sections. | Stain Technol | 1972 | https://conductscience.org/library/papers/4111887 | PubMed |
| 10 | 4623613 | Determination of body composition by neutron activation analysis in patient with renal failure. | J Lab Clin Med | 1972 | https://conductscience.org/library/papers/4623613 | PubMed |
| 11 | 4131033 | Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. | Lancet | 1974 | https://conductscience.org/library/papers/4131033 | PubMed |
| 12 | 4275344 | Intestinal absorption of calcium and the effect of renal insufficiency. | Kidney Int | 1973 | https://conductscience.org/library/papers/4275344 | PubMed |
| 13 | 4125790 | 1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure. | Lancet | 1973 | https://conductscience.org/library/papers/4125790 | PubMed |
| 14 | 4121843 | Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency. | Lancet | 1973 | https://conductscience.org/library/papers/4121843 | PubMed |
| 15 | 4131034 | Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man. | Lancet | 1974 | https://conductscience.org/library/papers/4131034 | PubMed |
| 16 | 4364427 | Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids. | Kidney Int | 1973 | https://conductscience.org/library/papers/4364427 | PubMed |
| 17 | 4333142 | The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. | Endocrinology | 1972 | https://conductscience.org/library/papers/4333142 | PubMed |
| 18 | 4342432 | Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D3, in uremic man. | N Engl J Med | 1972 | https://conductscience.org/library/papers/4342432 | PubMed |
| 19 | 4348463 | 1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 . | Science | 1973 | https://conductscience.org/library/papers/4348463 | PubMed |
| 20 | 4319631 | Unique biosynthesis by kidney of a biological active vitamin D metabolite. | Nature | 1970 | https://conductscience.org/library/papers/4319631 | PubMed |
| 21 | 4621774 | Determination of whole-body calcium by neutron activation analysis in vivo. | Semin Nucl Med | 1972 | https://conductscience.org/library/papers/4621774 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6307498 | Studies on the mode of action of vitamin D XXXVII 1 alpha-hydroxyvitamin D3: a long-acting 1,25-dihydroxyvitamin D3 analog. | Calcif Tissue Int | 1983 | https://conductscience.org/library/papers/6307498 | PubMed |
| 932193 | Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. | J Clin Invest | 1976 | https://conductscience.org/library/papers/932193 | PubMed |
| 912549 | 1alpha-Hydroxycholecalciferol in children with renal osteodystrophy. | Calcif Tissue Res | 1977 | https://conductscience.org/library/papers/912549 | PubMed |
| 879833 | Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol. | Arch Dis Child | 1977 | https://conductscience.org/library/papers/879833 | PubMed |
| 789876 | Renal bone disease. | J R Coll Physicians Lond | 1976 | https://conductscience.org/library/papers/789876 | PubMed |
| 782662 | 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease. | Calcif Tissue Res | 1976 | https://conductscience.org/library/papers/782662 | PubMed |
| 782661 | Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy. | Calcif Tissue Res | 1976 | https://conductscience.org/library/papers/782661 | PubMed |
| 334342 | Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure. | Calcif Tissue Res | 1977 | https://conductscience.org/library/papers/334342 | PubMed |
| 23950 | Therapeutic and collateral effects of 25-hydroxycholecalciferol in vitamin D deficiency. | Eur J Pediatr | 1977 | https://conductscience.org/library/papers/23950 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1120218
GET https://conductscience.org/api/papers/v1/1120218/references?page=2